Home  /  Resource Library  /  Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy

Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy

First prospective, controlled study to identify complex karyotypes as an independent prognostic factor of survival in CLL. First study to show that mutations in KRAS or POT1 impact treatment response and survival after chemoimmunotherapy.